Long-term follow-up of psilocybin-facilitated smoking cessation .
Long-term follow-up of psilocybin-facilitated smoking cessation
Am J Drug Alcohol Abuse. 2017 11-Apr;():. 10.3109/00952990.2016.1170135This is a long-term follow-up to a previously published pilot study which indicated that two to three moderate to high doses of psilocybin in combination with cognitive behavioural therapy resulted in 12 of 15 participants remaining abstinent from smoking after 6 months. This follow-up study found that 10 of 15 participants were abstinent from smoking, and at long term follow up (range 16-57 months) 9 of 12 participants were abstinent from smoking.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
